Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.
TORONTO, ONTARIO / ACCESSWIRE / October 26, 2020 / Novamind Ventures Inc. (“Novamind”), a mental health and wellness company specialized in psychedelic-assisted psychotherapy, is pleased to announce that it will present at PsyTech’s upcoming virtual summit: “A Global Dialogue on the Future of Psychedelic Medicine”. The event is set to take place on October 27th, 2020 and is free of charge for attendees.
From 6:00-7:00 PM EST, Novamind will present two talks titled
i) Global Access to Psychedelic Medicine and Innovative Research Hosted by: Yaron Conforti - Chief Executive Officer, Novamind
ii) Psychedelic Medicine: A Pathway Towards Systemic Healing Hosted by: Reid Robison, MD, MBA - Chief Medical Officer, Novamind and Adele Lafrance, PhD - Senior Consultant, Research Scientist, Novamind
The PsyTech Summit will be streamed from eight cities across the globe and will feature leaders in psychedelic research, therapy, technology, advocacy, and business. Other distinguished speakers include Rick Doblin, Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), Professor Matthew Johnson of Johns Hopkins University, author, psychiatrist and psychopharmacologist, Dr. Julie Holland, and Dr. Robin Carhart-Harris, Founder of the Centre for Psychedelic Research at Imperial College London.
For more information, or to register for the Psytech summit, visit www.psytech.biz.
About Novamind Novamind is building a global network of clinics, retreats and research sites to serve the regulated psychedelics industry. We provide access to safe, legal psychedelic experiences, while advancing research for psychedelic medicine. For more information visit www.novamind.ca.
Yaron Conforti, CEO and Director
T: +1 (647) 953 9512